TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -11 | -1 | 11 | 49 | 65 | -66 | 8 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/22 08:31 | 5/12/22 | IMUX | Immunic, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nash Duane | NY | DO | Exec CB | P | 50 | 5.03 | 0 | 10 | 166 | 16 | D | ||||||||||||||
8/11/21 09:02 | 8/10/21 | IMUX | Immunic, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nash Duane | NY | DO | Exec CB | P | 10 | 9.80 | 0 | 1 | 7 | 15 | D | ||||||||||||||
5/12/21 16:31 | 5/12/21 | IMUX | Immunic, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nash Duane | NY | DO | Exec CB | P | 51 | 12.75 | 0 | 4 | 40 | 14 | D | ||||||||||||||
6/9/17 16:06 | 6/8/17 | VTL | Vital Therapies Inc | DE | Health | Drug | Pharmaceutical Preparations | Nash Duane | CA | O | P | P | 12 | 3.12 | 0 | 4 | 90 | 8 | D | ||||||||||||||
10/9/14 21:09 | 10/8/14 | VTL | Vital Therapies Inc | DE | Health | Drug | Pharmaceutical Preparations | Nash Duane | CA | O | See Rema | P | 2 | 17.50 | 1 | 0 | 1 | 9 | D | -33 | -36 | -24 | -20 | -5 | -11 | -1 | 11 | 49 | 65 | -66 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |